Skip to main content

5 Result(s)

within Shih-Wen Lin Remove this filter

and

  1. Article

    Open Access

    Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA

    This study aimed to assess the budget impact of introducing fixed-duration mosunetuzumab as a treatment option for adult patients with relapsed or refractory follicular lymphoma after at least two prior system...

    Shih-Wen Lin, Sheila Shapouri, Hélène Parisé, Eric Bercaw, Mei Wu… in PharmacoEconomics (2024)

    Download PDF (1241 KB) View Article

  2. Article

    Open Access

    Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

    Vascular endothelial growth factor (VEGF), tyrosine kinase (TK) and mechanistic target of rapamycin kinase (mTOR) inhibitors are common first-line (1 L) treatments for metastatic renal cell carcinoma (mRCC). D...

    Sumanta Pal, Jun Gong, Shivani K. Mhatre, Shih-Wen Lin, Andy Surinach… in BMC Cancer (2019)

    Download PDF (1559 KB) View Article

  3. No Access

    Article

    Intra- and Intergenomic variation of Ploidy and Clonality characterize Phytophthora capsici on Capsicum sp. in Taiwan

    Phytophthora capsici is a devastating disease of pepper (Capsicum sp.) in Taiwan causing complete loss of commercial fields. The objective of this study was to characterize genetic divers...

    Derek W. Barchenger, Kurt H. Lamour, Zong-Ming Sheu… in Mycological Progress (2017)

  4. Article

    Open Access

    Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma

    Esophageal cancer is the sixth leading cause of cancer death worldwide; current early detection screening tests are inadequate. Esophageal balloon cytology successfully retrieves exfoliated and scraped superfi...

    Shih-Wen Lin, Christian C Abnet, Neal D Freedman, Gwen Murphy, Rosana Risques… in BMC Cancer (2013)

    Download PDF (300 KB) View Article

  5. No Access

    Article

    Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses

    Interactions between the herpesvirus entry mediator (HVEM) and the B- and T-lymphocyte attenuator (BTLA) inhibit B and T cell activation. HVEM-BTLA interactions are blocked by herpes simplex virus (HSV) glycop...

    Marcio O Lasaro, Nia Tatsis, Scott E Hensley, J Charles Whitbeck… in Nature Medicine (2008)